<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7372203\results\search\country\results.xml">
  <result pre="by intravenous infusion [20]. Other noncomparative, open-label studies underway in" exact="Greece" post="(NCT04356366, NCT04339712) and Belgium (NCT04330638) are using the subcutaneous"/>
  <result pre="Other noncomparative, open-label studies underway in Greece (NCT04356366, NCT04339712) and" exact="Belgium" post="(NCT04330638) are using the subcutaneous form. IL-6 Receptor Antagonists"/>
  <result pre="trials planned or initiated using tocilizumab in COVID-19 patients in" exact="the US," post="China, and Europe. Interim results from CORIMUNO-TOCI (NCT04331808), an"/>
  <result pre="III trial is taking place at a global level in" exact="the US," post="Canada, UK, and Europe (NCT04320615). The study will evaluate"/>
  <result pre="been used orally as a treatment for allergic rhinitis in" exact="Japan" post="for the past 20Ã‚ years. Hence, clinical trials investigating"/>
  <result pre="3.WuFZhaoSYuBet al.A new coronavirus associated with human respiratory disease in" exact="China" post="[published correction appears in Nature. 2020;580(7803):E7]Nature2020579779826526910.1038/s41586-020-2008-332015508 4.HuangCWangYLiXRenLZhaoJHuYet al.Clinical features"/>
  <result pre="medicine. Diagnosis and treatment protocol for novel coronavirus pneumonia. From" exact="China" post="consulate website. https://busan.china-consulate.org/chn/zt/4/P020200310548447287942.pdf. Accessed 20 Mar 2020. 27.LuoPLiuYQiuLLiuXLiuDLiJTocilizumab treatment"/>
  <result pre="from ChinaClin Immunol202021410839310.1016/j.clim.2020.10839332222466 61.I-Mab seeks approval for Covid-19 trial in" exact="South Korea." post="https://www.clinicaltrialsarena.com/news/i-mab-covid-19-drug-trial/. Accessed 14 May 2020. 62.Izana intiates study assessing"/>
 </snippets>
</snippetsTree>
